Imatinib is a multikinase inhibitor targeting PDGFR, ABL, c-KIT, that is already used for the treatment of gastrointestinal stromal tumor (GIST), and different types of leukemias (7). This evidence concerns the gene PDGFRB and gastrointestinal stromal tumor.